跳至主要内容
临床试验/NCT01179724
NCT01179724Unknown不适用

Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 206 人开始时间: 2009年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
206
试验地点
1
主要终点
bleeding incidence after ESD

研究概览

简要总结

after endoscopic submucosal dissection(ESD) of early gastric cancer, conventional proton pump(PPI) inhibitors and H2 receptor antagonists have a controversial effect on preventing bleeding from artificial ulcers. the aim of this study was to investigate whether a stronger acid suppression (high dose PPI) more effectively prevents bleeding after ESD

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • the patients who agreed informed consent
  • gastric adenoma or early gastric cancer which is eligible for conventional ESD indication

排除标准

  • recent drug history of PPI, H2 rector antagonist, bismuth and antibiotics within 4 weeks
  • recent drug history of anticoagulant or antiplatelet agent within 7 days
  • s/p subtotal gastrectomy
  • recurred gastric adenoma or cancer
  • pregnant or breast feeding patients

研究组 & 干预措施

high dose proton pump inhibitor

Experimental

干预措施: high dose proton pump inhibitor (Drug)

H2 receptor antagonist

Active Comparator

干预措施: H2RB (Drug)

结局指标

主要结局

bleeding incidence after ESD

时间窗: time to occur delayed bleeding within one month after ESD

次要结局

  • the size of healing ulcer after ESD(follow up endoscopy for the healing of iatrogenic ulcer after one month ESD)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验